 |
Herbal Medicine for Heart Attack, Avoid Heart Bypass Surgery |
|
| |
|
|
|
|
|
|
| |
Based on the success of applying Tridosha Principles of Ayurveda in treating CAD patients, RUDVED was invented in December 2005. Based on the feedback received from the patients and the research conducted by our team of doctors, the formula of Rudved was modified by adding more Wellness in 2008. In compliance with the FDA requirements, the new modified product has been named as WRUDVED. Empty capsules used in WRUDVED are 100% vegetarian of plant origin.
We have modified the formula of WRUDVED further and brought out more effective and more adoptable formula in 2014 and named it as HRUDVED A Herbal Highway for Healthy Heart. HRUDVED has 12 ingredients against 10 ingredients in WRUDVED.
|
|
| |
Composition: |
|
|
|
|
|
|
|
|
|
Each HRUDVED Capsule contains Powders of : |
|
|
Following INGREDIENTS included in the HRudved Capsule |
|
|
|
|
|
|
|
|
|
|
| Arjun (Terminalia Arjuna) Sal |
40 mg |
| Ajmoda (Apium Graveolens) Seed |
40 mg |
| Pimpali (Piper Longum) Fruits |
90 mg |
| Draksha (Vitis Vinifera) Seed |
40 mg |
| Twak (Cinnamomum) Bark |
30 mg |
| Nagarmotha (Cyperus Rotundus) Rhizome |
30 mg |
| Shuddha Guggul (Commifora Mukul) Niryas |
30 mg |
| Chitrak (Plumbago) Root |
25 mg |
| Triphala Ext. (Three Myrobalons) Fruits |
40 mg |
| Excipients |
Q.S. |
| Bhavana Process with Dalimb Ras |
One Bhavana |
|
|
|
|
|
|
|
|
|
|
|
RUDVED capsules have been tested by SGS India Pvt.Ltd., Chennai for heavy metal contents and it was established that the findings are much below the permissible limit approved by the WHO and FDA.
PERMISSIBLE LIMIT OF HEAVY METALS IN AYURVEDA, SIDDHA & UNANI MEDICINES WITH ONLY HERBAL INGREDIENTS as per W.H.O & F.D.A |
|
|
|
|
|
|
|
|
|
Source: http://indianmedicine.nic.in/html/news/perm.pdf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis done by SGS India Pvt. Ltd., Chennai, vide Report NO.7615005229 dated 25.06.2007. (Sample No. CH:LS:7610005325) |
|
|
Result of the Diagnostic Tests conducted on selected 500 patients with RUDVED : |
|
|
|
| |
No. of Patients |
Pre-Treatment Test
|
Post-Treatment Test |
| 1 |
150 |
3DCCG |
3DCCG |
| 2 |
50 |
ANGIOGRAPHY |
ANGIOGRAPHY |
| 3 |
25 |
ANGIOGRAPHY |
3DCCG |
| 4 |
25 |
ANGIOGRAPHY |
STRESS THALIUM |
| 5 |
150 |
ECG |
ECG |
| 6 |
50 |
STRESS THALIUM |
STRESS THALIUM |
| 7 |
50 |
ECG, 2D ECHO |
SYMPTOMATIC |
|
|
|
|
|
|
|
|
|
|
|
|
Generally, there is no scientific evidence recorded for the result of Rudved in treating coronary artery disease. The reason is that Ayurveda is not an evidence based science. The ingredients are already in existence since centuries and we have arrived at a formula based on the feedback received in treating CAD patients with Tridosha principles of Ayurved.
Criteria of Medicine selected were irrespective of age, sex etc. Most of patients were studied on OPD level & some of them were studied on Hospital level. |
|
|
Criteria of Diagnosis |
|
|
Patients were diagnosed on the basis of signs & symptoms of Vataj, Pittaj and Kaphaj described in text. The special case paper was prepared. On the basis of pre & post reports of E.C.G. stress test, Angiography, Stress Thallium (Myocardial Perfusion study), 3.D.C.C.G. Blood reports (Cardiac Profile) etc. - Detailed Clinical history was taken. |
|
|
Management of Patients |
|
|
All the patients diagnosed were divided into 4 groups in random manner & treated accordingly. The total duration of treatment was 12-18 weeks. The Medicine RUDVED was made available for all centres. While treating the patients, during the first month of treatment we never stopped their Allopathic Medicine to prevent withdrawal symptoms. Allopathy was tapered down gradually and stopped.
Criteria of assessment - The improvement in the patients were assessed on the basis of relief in the signs and symptoms as well as their various pre & post reports such as angiography, 3 D.C.C.G. etc. |
|
|
|
|
|
Results |
|
|
Total 500 patients Were registered.
In this study 86.25% cases of 35 to 65 yrs. Age group and 13.75% were above 65 yrs.
Sex:
59.94% pts were female 41.06% pts were male |
|
|
|
|
|
Remarks |
|
|
This study was conducted for a period of 12-18 weeks , which may be considered a short period in comparison with the natural history of a disease that was a significant improvement in CAD, specific parameters in all patients who received RUDVED in this short period of time. There were no clinically significant adverse reactions noted with the RUDVED, which suggest excellent safety of RUDVED.
Most of the patients have done diagnostic investigations like angiography, 3DCCG, Stress Test, ECG etc. Treatment was given for 2 to 6 months. Most of the patients were reluctant to undergo post treatment [second time] test because they have been treated fully and not willing to spend money again for the second test. It was proved that blocks from coronary arteries could be successfully treated by use of Tridosh principles of Ayurved.
HRUDVED is Manufactured by Chaitrali Herbocos, S.No. 30/15, Bldg. No. 6, Unity Industrial Estate, A.P. Dhayari, Tal: Haveli, Dist.: Pune - 411041 having Mfg. Lic.No.:MH/102317A and Manufactured At: Everest Pharma, S.No.30/14, Unit Nos.3, 4, 13 &14, A.P. Dhayari, Tal.Haveli, Dist.Pune-411041, India.
Solely Distributed By:
SUBBIES HERBO CARE ,
102, Dharti Complex - B,
Evershine Enclave,
Opp: Wockhardt (Umrao) Hospitals,
Mira Road (East) - 401107
Dist: Thane, Maharashtra, INDIA
Recommended Dosage: 1 to 3 capsules per day to be taken after food or as prescribed by the Physician.
|
|
